Kraig Biocraft Laboratories, Inc.
KBLB
$0.085
-$0.004-4.49%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 556.60K | 655.40K | 398.80K | 1.44M | 419.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 580.50K | 715.90K | 423.80K | 1.49M | 448.70K |
| Operating Income | -580.50K | -715.90K | -423.80K | -1.49M | -448.70K |
| Income Before Tax | -600.00K | -851.70K | -433.20K | -1.61M | -507.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -600.00K | -851.70K | -433.20K | -1.61M | -507.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -600.00K | -851.70K | -433.20K | -1.61M | -507.90K |
| EBIT | -580.50K | -715.90K | -423.80K | -1.49M | -448.70K |
| EBITDA | -574.80K | -709.90K | -417.10K | -1.48M | -442.00K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 1.04B | 1.04B | 1.04B | 1.04B | 1.04B |
| Average Diluted Shares Outstanding | 1.04B | 1.04B | 1.04B | 1.04B | 1.04B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |